The direct-to-consumer laboratory testing market would grow at a CAGR of 34.72% over the predicted time frame. The market is expected to increase in value from US$ 3 Bn in 2022 to US$ 32.6 Bn in 2030.

The on direct-to-consumer laboratory testing Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2313

A recent report provides crucial insights along with application based and Forecast information in the Global Direct-to-consumer laboratory testing Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Direct-to-consumer laboratory testing market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Direct-to-consumer laboratory testing market are included as given below:

Direct-to-consumer laboratory testing Market Key Players

• 23andMe, Inc
• Ambry Genetics Corp.
• Ancestry.com LLC
• Any Lab Test Now, Inc.
• Color Genomics, Inc
• Counsyl, Inc.
• DanteLabs Inc.
• Direct Laboratory Services, LLC
• Eastern Biotech & Life Sciences
• EasyDNA
• EverlyWell, Inc., 
• Full Genomes Corporation, Inc.
• Gene by Gene, Ltd.
• Genecodebook Oy
• Genesis Healthcare Co.
• Genetrainer
• GHC Genetics UK
• HealthCheckUSA
• Home Access Health Corporation
• International Biosciences
• Laboratory Corporation of America Holdings
• LetsGetChecked, Inc.
• Mapmygenome India Limited
• Medichecks.com Ltd.
• MyHeritage Ltd.
• MyMedLab, Inc., 
• Myriad Genetics, Inc.
• Natera, Inc
• OME Care
• Pathway Genomics
• Pixel by LabCorp, 
• Positive Bioscience
• Quest Diagnostics Incorporated, 
• Request A Test, Ltd.
• Shuwen Biotech Co. Ltd.
• Sonora Quest Laboratories, 
• Thryve Inc
• Ulta Lab Tests, LLC, 
• Veritas Genetics
• Vitagene, Inc.
• Walk-In Lab, LLC., 
• WellnessFX, Inc.
• Xcode Life Sciences

Market Segments

By Product

• Medical Genetic Laboratory Testing
• Routine Clinical Laboratory Testing

By Test Type

• Genetic Testing
• COVID-19
• Cancer
• Diabetes Testing
• Disease Risk Assessment Testing
• Sexually Transmitted Disease Testing
• Routine Testing
• Complete Blood Count
• CNS-related/Neurological Disease
• Thyroid Stimulating Hormone Testing
• Other

By Sample Type

• Blood
• Urine
• Saliva
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global direct-to-consumer laboratory testing market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the direct-to-consumer laboratory testing market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Direct-to-Consumer Laboratory Testing Market 

5.1. COVID-19 Landscape: Direct-to-Consumer Laboratory Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Direct-to-Consumer Laboratory Testing Market, By Product

8.1. Direct-to-Consumer Laboratory Testing Market, by Product, 2023-2032

8.1.1 Medical Genetic Laboratory Testing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Routine Clinical Laboratory Testing

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Direct-to-Consumer Laboratory Testing Market, By Test Type

9.1. Direct-to-Consumer Laboratory Testing Market, by Test Type, 2023-2032

9.1.1. Genetic Testing

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. COVID-19

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Diabetes Testing

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Disease Risk Assessment Testing

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Sexually Transmitted Disease Testing

9.1.6.1. Market Revenue and Forecast (2020-2032)

9.1.7. Routine Testing

9.1.7.1. Market Revenue and Forecast (2020-2032)

9.1.8. Complete Blood Count

9.1.8.1. Market Revenue and Forecast (2020-2032)

9.1.9. Complete Blood Count

9.1.9.1. Market Revenue and Forecast (2020-2032)

9.1.10. Thyroid Stimulating Hormone Testing

9.1.10.1. Market Revenue and Forecast (2020-2032)

9.1.11. Other

9.1.11.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Direct-to-Consumer Laboratory Testing Market, By Sample Type 

10.1. Direct-to-Consumer Laboratory Testing Market, by Sample Type, 2023-2032

10.1.1. Blood

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Urine

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Saliva

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Direct-to-Consumer Laboratory Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Sample Type (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Test Type (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Sample Type (2020-2032)

Chapter 12. Company Profiles

12.1. 23andMe, Inc

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Ambry Genetics Corp.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Ancestry.com LLC

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Any Lab Test Now, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Color Genomics, Inc

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Counsyl, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. DanteLabs Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Direct Laboratory Services, LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Eastern Biotech & Life Sciences

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. EasyDNA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com